Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion

Josué Guillermo López; Jhyld Carolaind Camacho-Barbosa; Oscar Jair Felipe-Díaz; Wilmer Gerardo Rojas-Zuleta; Jesús Giovanny Ballesteros; Erika Paola Navarro-Mendoza; Claudia Lucía Giraldo Herrera; Rodrigo Giraldo-Bustos; Lácides Padilla-Tovar; Natalia Duque-Zapata; Catalina Orozco González; María José López-Mora; Jorge Hernando Donado

doi:10.1016/j.rcreu.2020.05.021

Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion

Translated title of the contribution: Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion

Josué Guillermo López, Jhyld Carolaind Camacho-Barbosa, Oscar Jair Felipe-Díaz, Wilmer Gerardo Rojas-Zuleta, Jesús Giovanny Ballesteros, Erika Paola Navarro-Mendoza, Claudia Lucía Giraldo Herrera, Rodrigo Giraldo-Bustos, Lácides Padilla-Tovar, Natalia Duque-Zapata, Catalina Orozco González, María José López-Mora, Jorge Hernando Donado

Research output: Contribution to journal › Article in an indexed scientific journal › peer-review

Abstract

Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.

Translated title of the contribution	Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion
Original language	English
Pages (from-to)	134-140
Number of pages	7
Journal	Revista Colombiana de Reumatologia
Volume	28
Issue number	2
DOIs	https://doi.org/10.1016/j.rcreu.2020.05.021
State	Published - 1 Apr 2021
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020 Asociación Colombiana de Reumatología

Keywords

Antimalarials
COVID-19
Coronavirus
Drug Therapy
Rheumatology

Access to Document

10.1016/j.rcreu.2020.05.021

Cite this

López, J. G., Camacho-Barbosa, J. C., Felipe-Díaz, O. J., Rojas-Zuleta, W. G., Ballesteros, J. G., Navarro-Mendoza, E. P., Giraldo Herrera, C. L., Giraldo-Bustos, R., Padilla-Tovar, L., Duque-Zapata, N., Orozco González, C., López-Mora, M. J., & Donado, J. H. (2021). Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion. Revista Colombiana de Reumatologia, 28(2), 134-140. https://doi.org/10.1016/j.rcreu.2020.05.021

@article{4095c048144b45e8bbf7e3ab1582e620,

title = "Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion",

abstract = "Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.",

keywords = "Antimalarials, COVID-19, Coronavirus, Drug Therapy, Rheumatology",

author = "L{\'o}pez, {Josu{\'e} Guillermo} and Camacho-Barbosa, {Jhyld Carolaind} and Felipe-D{\'i}az, {Oscar Jair} and Rojas-Zuleta, {Wilmer Gerardo} and Ballesteros, {Jes{\'u}s Giovanny} and Navarro-Mendoza, {Erika Paola} and {Giraldo Herrera}, {Claudia Luc{\'i}a} and Rodrigo Giraldo-Bustos and L{\'a}cides Padilla-Tovar and Natalia Duque-Zapata and {Orozco Gonz{\'a}lez}, Catalina and L{\'o}pez-Mora, {Mar{\'i}a Jos{\'e}} and Donado, {Jorge Hernando}",

note = "Publisher Copyright: {\textcopyright} 2020 Asociaci{\'o}n Colombiana de Reumatolog{\'i}a",

year = "2021",

month = apr,

day = "1",

doi = "10.1016/j.rcreu.2020.05.021",

language = "Ingl{\'e}s",

volume = "28",

pages = "134--140",

journal = "Revista Colombiana de Reumatologia",

issn = "0121-8123",

publisher = "Asociacion Colombiana de Reumatologia",

number = "2",

}

López, JG, Camacho-Barbosa, JC, Felipe-Díaz, OJ, Rojas-Zuleta, WG, Ballesteros, JG, Navarro-Mendoza, EP, Giraldo Herrera, CL, Giraldo-Bustos, R, Padilla-Tovar, L, Duque-Zapata, N, Orozco González, C, López-Mora, MJ & Donado, JH 2021, 'Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion', Revista Colombiana de Reumatologia, vol. 28, no. 2, pp. 134-140. https://doi.org/10.1016/j.rcreu.2020.05.021

Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion. / López, Josué Guillermo; Camacho-Barbosa, Jhyld Carolaind; Felipe-Díaz, Oscar Jair et al.
In: Revista Colombiana de Reumatologia, Vol. 28, No. 2, 01.04.2021, p. 134-140.

Research output: Contribution to journal › Article in an indexed scientific journal › peer-review

TY - JOUR

T1 - Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency

T2 - Expert group opinion

AU - López, Josué Guillermo

AU - Camacho-Barbosa, Jhyld Carolaind

AU - Felipe-Díaz, Oscar Jair

AU - Rojas-Zuleta, Wilmer Gerardo

AU - Ballesteros, Jesús Giovanny

AU - Navarro-Mendoza, Erika Paola

AU - Giraldo Herrera, Claudia Lucía

AU - Giraldo-Bustos, Rodrigo

AU - Padilla-Tovar, Lácides

AU - Duque-Zapata, Natalia

AU - Orozco González, Catalina

AU - López-Mora, María José

AU - Donado, Jorge Hernando

PY - 2021/4/1

Y1 - 2021/4/1

N2 - Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.

AB - Coronavirus 2019 (COVID-19) is an unexpected pandemic that has caused a state of emergency, as well as generating drastic changes in clinical care protocols. Some drugs commonly used in rheumatoid arthritis, systemic lupus erythematosus, and other systemic autoimmune diseases have been described for its treatment. Therefore, there is an imminent risk of shortages. The aim of this narrative review and expert opinion is to present general recommendations on the clinical and administrative management of outpatients with autoimmune or systemic inflammatory disease, in the context of the COVID-19 pandemic.

KW - Antimalarials

KW - COVID-19

KW - Coronavirus

KW - Drug Therapy

KW - Rheumatology

UR - http://www.scopus.com/inward/record.url?scp=85088145239&partnerID=8YFLogxK

U2 - 10.1016/j.rcreu.2020.05.021

DO - 10.1016/j.rcreu.2020.05.021

M3 - Artículo en revista científica indexada

AN - SCOPUS:85088145239

SN - 0121-8123

VL - 28

SP - 134

EP - 140

JO - Revista Colombiana de Reumatologia

JF - Revista Colombiana de Reumatologia

IS - 2

ER -

Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this